SARC 024: A blanket protocol to study oral regorafenib in patients with refractory liposarcoma, osteogenic sarcoma, and Ewing/Ewing-like sarcomas - Cohort A
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Sarcoma Alliance for Research Through Collaboration
Start Date
September 1, 2015
End Date
August 31, 2018
Administered By
Duke Cancer Institute
Awarded By
Sarcoma Alliance for Research Through Collaboration
Start Date
September 1, 2015
End Date
August 31, 2018